Citations

Showing 10 of 108104 citations.

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
Boysen, Justin C. , Chaffee, Kari G. , Kabat, Brian, Secreto, Charla, Call, Tim G., Shanafelt, Tait D. , Leis, José F., Warner, Steven L. , Bearss, David J. , Ghosh, Asish K. , Rabe, Kari G. , Kabat, Brian F, Secreto, Charla R, Call, Tim, Shanafelt, Tait D , Sinha, Sutapa , Slager, Susan L. , Parikh, Sameer A. , Call, Timothy G., Bearss, David J. , Kay, Neil E.

Mayo Clinic

Oncotarget | December 14, 2018 | Volume: 9 | Issue: 98 | Pages: 37173-37184

10.18632/oncotarget.26444 | PMID 30647852 Get It

The Role of Heart Rate Variability Biofeedback in Pediatric Chronic Pain Rehabilitation: A Case Series Design
Fahrenkamp, Amy J., Benore, Ethan

Mayo Clinic

Clinical Practice in Pediatric Psychology | December 14, 2018 | Volume: 7 | Issue: 4 | Pages: 358-370

10.1037/cpp0000259 Get It

Biofeedback is 1 form of complementary therapy commonly used to treat pediatric chronic pain. Given the limited research in biofeedback treatment outcomes with youth experiencing chronic pain, the present study sought to initially examine the potential for heart rate variability (HRV) biofeedback to support self-regulation training for adolescents participating in a chronic pain rehabilitation program. Using a case series design, this study examined changes in HRV and respiration rate for 4 adolescents with chronic pain. Adolescents completed an initial assessment followed by 3–4 biofeedback training sessions. The Nexus 10 biofeedback system (BioTrace+ software) was used to obtain respiration rate and HRV low-frequency percentage. Visual inspection of plotted graphs from adolescents’ HRV biofeedback training demonstrated (a) improved cardiopulmonary functioning across sessions during active training, (b) changed cardiopulmonary functioning across sessions during baseline assessment, and (c) improved functioning without active feedback, suggesting self-regulation of cardiopulmonary functioning. Adolescents using a brief protocol of HRV biofeedback training demonstrated expected changes in cardiopulmonary functioning and self-regulation. Similar to findings in adults, HRV biofeedback yields promise as an intervention to treat children with chronic pain and comorbid symptoms. However, because this is an initial study, additional research with more rigorous methodology is needed to further support the benefit of HRV biofeedback in modifying physiological awareness and self-regulation and the connection of this self-regulation with clinical outcomes. Future clinical research should build on these initial findings to develop and test biofeedback protocols to treat chronic pain in children. Implications for Impact Statement Findings from this case series design showed initial benefits in increasing adolescents’ physiological self-regulation skills. Providers may draw clinical applications from these self-regulation techniques within and outside of a biofeedback context to teach increased awareness, control, and generalization of self-regulatory skills to cope with negative experiences.
Response of the Injured Tendon to Growth Factors in the Presence or Absence of the Paratenon
Quirk, Nicholas , Müller-Lebschi, Julia A., Heisterbach, Patricia E., Dürselen, Lutz , Majewski, Martin , Evans, Christopher H. , Müller, Sebastian A. , Quirk, Nicholas P, Quirk, Nicholas , Müller, Sebastian

Mayo Clinic

The American Journal of Sports Medicine | December 14, 2018 | Volume: 47 | Issue: 2 | Pages: 462-467

10.1177/0363546518814534 | PMID 30550720 Get It

Background: The paratenon is important for Achilles tendon healing. There is much interest in the use of exogenous growth factors (GFs) as potential agents for accelerating the healing of damaged Achilles tendons. Purpose/Hypothesis: The present study used a rat model to study the responses of the injured Achilles tendon to GFs in the presence or absence of the paratenon. The hypothesis was that responses of the injured tendon to GFs would be lower in the absence of a paratenon. Study Design: Controlled laboratory study. Methods: A 4-mm defect was created in the right Achilles tendon of 60 skeletally mature rats, which were treated with a validated combination of GFs (bFGF, BMP-12, and TGF-β1). Animals were randomly assigned to the intact paratenon (IP) group or resected paratenon (RP) group. Healing was studied anatomically, mechanically, and histologically after 1, 2, and 4 weeks. Results: IP tendons showed improved healing compared with RP tendons. IP tendons were significantly stronger (32.2 N and 48.9 N, respectively) than RP tendons (20.1 N and 31.1 N, respectively) after 1 and 2 weeks. IP tendons did not elongate as much as RP tendons and had greater cross-sectional areas (18.0 mm 2 , 14.4 mm 2 , and 16.4 mm 2 , respectively) after 1, 2, and 4 weeks compared with RP tendons (10.5 mm 2 , 8.4 mm 2 , and 11.9 mm 2 , respectively). On histology, earlier collagen deposition and parallel orientation of fibrils were found for IP tendons. Conclusion: The paratenon is essential for efficient Achilles tendon healing. Healing with GFs in this Achilles tendon defect model was superior in the presence of the paratenon. Clinical Relevance: Biological approaches to tendon engineering using GFs are in vogue and have been shown to improve healing of the rat Achilles tendon, most likely by inducing progenitor cells located within the paratenon. Clinically, resection or incision of the paratenon has been proposed for wound closure. Our data demonstrate the fundamental importance of the paratenon, which therefore should be preserved during Achilles tendon repair, especially if augmented with products such as platelet-rich plasma or autologous conditioned serum that are rich in GFs.
Clinical Use of a Home Sleep Apnea Test: An Updated American Academy of Sleep Medicine Position Statement
Rosen, Ilene M. , Kirsch, Douglas B. , Carden, Kelly A., Malhotra, Raman K. , Ramar, Kannan , Aurora, R. Nisha , Kristo, David A., Olson, Eric J. , Rosen, Carol L. , Rowley, James A. , Shelgikar, Anita V., Martin, Jennifer L.

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2018 | Volume: 14 | Issue: 12 | Pages: 2075-2077

10.5664/jcsm.7540 | PMID 30518456 Get It

Practical Implementation of a Single-Night Split-Titration Protocol With BPAP-ST and AVAPS in Patients With Neuromuscular Disease
Patel, Salma , Gay, Peter C. , Olson, Eric J. , Shamoun, Fadi , Herold, Daniel L. , McNamara, Sarah, Selim, Bernardo J., Patel, Salma I, Gay, Peter, Morgenthaler, Timothy I. , Shamoun, Fadi E., Herold, Daniel, Selim, Bernardo, Kashyap, Rahul , McNamara, Sarah

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2018 | Volume: 14 | Issue: 12 | Pages: 2031-2035

10.5664/jcsm.7530 | PMID 30518448 Get It

Varying Hypopnea Definitions Affect Obstructive Sleep Apnea Severity Classification and Association With Cardiovascular Disease
Won, Christine , Selim, Bernardo J., Selim, Bernardo, Li, Qin , Yaggi, Henry Klar

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2018 | Volume: 14 | Issue: 12 | Pages: 1987-1994

10.5664/jcsm.7520 | PMID 30518445 Get It

Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses
Gupta, Kapil , Nagappa, Mahesh , Abrahamyan, Lusine , Wong, Jean , Chung, Frances , Wong, Jean , Gupta, Kapil, Prasad, Arun , Weingarten, Toby N.

Mayo Clinic

BMJ Open | December 14, 2018 | Volume: 8 | Issue: 12 | Pages: e024086

10.1136/bmjopen-2018-024086 | PMID 30552274 Get It

Objective This systematic review and meta-analysis aim to evaluate the risk factors associated with postoperative opioid-induced respiratory depression (OIRD). Design Systematic review and meta-analysis. Data sources PubMed-MEDLINE, MEDLINE in-process, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, PubMed and Clinicaltrials.gov (January 1946 to November 2017). Eligibility criteria The inclusion criteria were: (1) adult patients 18 years or older who were administered opioids after surgery and developed postoperative OIRD (OIRD group); (2) all studies which reported both OIRD events and associated risk factors; (3) all studies with reported data for each risk factor on patients with no OIRD (control group) and (4) published articles in English language. Data analysis We used a random effects inverse variance analysis to evaluate the existing evidence of risk factors associated with OIRD. Newcastle-Ottawa scale scoring system was used to assess quality of study. Results Twelve observational studies were included from 8690 citations. The incidence of postoperative OIRD was 5.0 cases per 1000 anaesthetics administered (95% CI: 4.8 to 5.1; total patients: 841 424; OIRD: 4194). Eighty-five per cent of OIRD occurred within the first 24 hours postoperatively. Increased risk for OIRD was associated with pre-existing cardiac disease (OIRD vs control: 42.8% vs 29.6%; OR: 1.7; 95% CI: 1.2 to 2.5; I 2 : 0%; p<0.002), pulmonary disease (OIRD vs control: 17.8% vs 10.3%; OR: 2.2; 95% CI: 1.3 to 3.6; I 2 : 0%; p<0.001) and obstructive sleep apnoea (OIRD vs control: 17.9% vs 16.5%; OR: 1.4; 95% CI: 1.2 to 1.7; I 2 : 31%; p=0.0003). The morphine equivalent daily dose of the postoperative opioids was higher in the OIRD group than in the control; (24.7±14 mg vs 18.9±13.0 mg; mean difference: 2.8; 95% CI: 0.4 to 5.3; I 2 : 98%; p=0.02). There was no significant association between OIRD and age, gender, body mass index or American Society of Anesthesiologists physical status. Conclusion Patients with cardiac, respiratory disease and/or obstructive sleep apnoea were at increased risk for OIRD. Patients with postoperative OIRD received higher doses of morphine equivalent daily dose.
A case of YY1‐associated syndromic learning disability or Gabriele‐de Vries syndrome with myasthenia gravis
Morales‐Rosado, Joel A. , Kaiwar, Charu , Smith, Benn E., Klee, Eric W. , Dhamija, Radhika , Morales-Rosado, Joel A , Dhamija, Radhika

Mayo Clinic

American Journal of Medical Genetics Part A | December 14, 2018 | Volume: 176 | Issue: 12 | Pages: 2846-2849

10.1002/ajmg.a.40626 | PMID 30549423 Get It

AbstractExome sequencing is being used increasingly to evaluate patients with intellectual disability. YY1 is a ubiquitously distributed transcription factor belonging to the GLIKruppel class of zinc finger proteins recently recognized as the causative gene in 23 patients for the Gabriele‐de Vries syndrome. We report a new case with similar features and a novel variant in YY1, in a region of the gene, which has not previously been reported. A 25 year old female was referred to clinical genetics with a diagnosis of autoimmune myasthenia gravis, facial dysmorphism and learning disability. Chromosomal microarray and gene panel test for congenital myasthenic syndrome was negative. Whole exome sequencing (WES) revealed a presumed pathogenic de novo novel, heterozygous, truncating variant in the YY1 gene, c.860_864delTTAAAA, p.Ile287Argfs*3. The Ile287 residue is conserved across species and is situated in the transcription repressor domain of the protein. This variant is novel and lies in a domain of the protein where no previously reported variants occur. The phenotypic features of our case closely match those of the reported patients. Autoimmune myasthenia gravis has not been reported in these patients and may constitute an expansion of this phenotypic spectrum or perhaps more likely a second unrelated diagnosis.
Chronic Obstructive Pulmonary Disease Phenotype Dictates Cancer-Promoting Stromal Gene Expression Programs
Wendt, Chris H. , Sandri, Brian J. , Masvidal, Laìa , Murie, Carl , Bartish, Margarita , Avdulov, Svetlana, Higgins, LeeAnn, Larsson, Ola , Wendt, Chris H , Larsson, Ola , Markowski, Todd W. , Peterson, Mark, Bergh, Jonas , Yang, Ping , Rolny, Charlotte , Limper, Andrew H. , Griffin, Timothy J. , Bitterman, Peter B.

Mayo Clinic

Annals of the American Thoracic Society | December 14, 2018 | Volume: 15 | Issue: Supplement_4 | Pages: S290-S291

10.1513/annalsats.201806-421mg Get It

Abstract Rationale Chronic obstructive pulmonary disease (COPD) is an independent risk factor for lung cancer, but the underlying molecular mechanisms are unknown. We hypothesized that stromal cells comprising the COPD lung contain pathological gene expression programs supporting oncogenesis. Objectives To identify molecular mechanisms operating in the lung stroma that support the development of lung cancer. Methods Study subjects included patients with COPD with (n = 30) or without (n = 30) lung cancer across a spectrum of COPD severity. We conducted multi-omics analysis of nonmalignant lung tissue to quantify the transcriptome, translatome, and proteome. Results Cancer-associated gene expression changes predominantly manifested as alterations in the efficiency of mRNA translation impacting protein levels in the absence of corresponding changes in mRNA levels. The molecular mechanisms driving these procancer translation programs differed on the basis of COPD severity. In mild or no COPD, the mammalian target of rapamycin pathway served as an upstream driver; whereas in advanced COPD, pathways downstream of pathological extracellular matrix emerged. Both the mammalian target of rapamycin and extracellular matrix gene expression programs paralleled activation of previously identified secretomes that can be independently induced and promote cancer initiation in mouse models. These included the senescence secretome in mild to no COPD and the ETS2 (erythroblast transformation-specific 2) secretome in moderate to severe COPD. Furthermore, in situ examination of COPD lung tissue documented stromal fibroblasts expressing key cancer-associated proteins from procancer secretomes including IL-6 (senescence secretome) in mild COPD and bone morphogenetic protein-1 (ETS2 secretome) in advanced COPD. Conclusions Two distinct stromal gene expression programs promoting cancer initiation are activated in patients with lung cancer depending on the severity of COPD as measured by lung function. Our work has implications both for screening strategies and personalized approaches to prevent cancer in COPD.
History‐indicated cervical cerclage in management of twin pregnancy
Rottenstreich, Amihai , Levin, Gabriel , Kleinstern, Geffen , Zigron, Roy, Rottenstreich, Misgav , Elchalal, Uriel , Yagel, Simcha , Levin, G , Yagel, S , Rottenstreich, M

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | December 14, 2018 | Volume: 54 | Issue: 4 | Pages: 517-523

10.1002/uog.20192 | PMID 30549119 Get It

ABSTRACTObjectiveCervical cerclage, when performed in twin gestation, has been reported to be associated with poor outcome. However, the role of first‐trimester history‐indicated cerclage among women with a twin pregnancy and a history of preterm birth has not been evaluated. The aim of this study was to assess pregnancy outcomes among women with a twin pregnancy who underwent first‐trimester history‐indicated cervical cerclage compared with outcomes in those managed expectantly.MethodsThis was a retrospective matched case–control study. The study group comprised all women with a twin pregnancy who had undergone first‐trimester history‐indicated cerclage during the period 2006 to 2017 at Hadassah‐Hebrew University Medical Center. A control group of women with a twin pregnancy who were managed expectantly was established by matching age, history of spontaneous preterm birth (20–36 weeks' gestation) and year of delivery. Pregnancy and delivery characteristics and neonatal outcomes were compared between the two groups.ResultsData from 82 women with a twin gestation were analyzed, of whom 41 underwent first‐trimester history‐indicated cerclage and 41 were matched controls who were managed expectantly. Gestational age at delivery was higher in the cerclage group than in those managed expectantly (median 35 vs 30 weeks; P < 0.0001). Rates of spontaneous preterm birth before 24 weeks (2.4% vs 19.5%; odds ratio (OR), 0.10 (95% CI, 0.01–0.87); P = 0.03), before 28 weeks (12.2% vs 34.1%; OR, 0.27 (95% CI, 0.09–0.84); P = 0.03), before 32 weeks (22.0% vs 56.1%; OR, 0.22 (95% CI, 0.08–0.58); P = 0.003) and before 34 weeks (34.1% vs 82.9%; OR, 0.11 (95% CI, 0.04–0.30); P < 0.0001) were significantly lower in the cerclage group than in the control group. Median birth weight was higher in the cerclage group (2072 g vs 1750 g; P = 0.003), with lower rates of low birth weight (< 2500 g) (65.0% vs 89.4%; P = 0.001) and very low birth weight (< 1500 g) (21.3% vs 37.9%; P = 0.03) than in the group managed expectantly. Rates were also lower in the cerclage group for stillbirth, admission to the neonatal intensive care unit, respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, neonatal mortality and composite adverse neonatal outcome.ConclusionsHistory‐indicated cerclage performed in the first trimester, as compared with expectant management, in women with a twin pregnancy had an overall positive effect on pregnancy and neonatal outcomes. These findings suggest the need for adequate randomized trials on cerclage placement in this subset of women. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.